After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Esperion Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Esperion Therapeutics Inc is $489.94M. A total of 6.6 million shares were traded on the day, compared to an average of 4.65M shares.
In the most recent transaction, Looker Benjamin sold 1,304 shares of ESPR for 1.13 per share on Jul 17 ’25. After the transaction, the General Counsel now owns 399,937 company shares. In a previous transaction on Jul 17 ’25, Halladay Benjamin sold 11 shares at 1.11 per share. ESPR shares that Chief Financial Officer owns now total 474,462.
Among the insiders who bought shares, Looker Benjamin acquired of 1,304 shares on Jul 17 ’25 at a per-share price of $1.13. In another insider transaction, Halladay Benjamin bought 11 shares at $1.12 per share on Jul 17 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ESPR has a high of $3.94 and a low of $0.69.
As of this writing, ESPR has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.11. The company reported an EPS of -$0.15 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$2.17, while its Total Shareholder’s Equity was -$196.94M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 3.89.
